BIO Comments On Follow-On Biologics Will Include Manufacturing Anecdotes
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA officials' questions to industry reps during public workshop focus on the level of studies that should be required for follow-on biologic applications, particularly in comparison to requirements for manufacturing process changes by innovators.